Publicaciones

30 de ENE - 2024 Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy

30 de ENE - 2024 Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence

30 de ENE - 2024 Global view of vasomotor symptoms and sleep disturbance in menopause: a systematic review

30 de ENE - 2024 Ischemia but no obstructive coronary artery disease: more than meets the eye

30 de ENE - 2024 Lack of evidence that progesterone in ovulatory cycles causes breast cancer

30 de ENE - 2024 Marketing the menopause

30 de ENE - 2024 Menopause and diabetes

30 de ENE - 2024 Menopause hormone treatment after cancer

30 de ENE - 2024 Primary prevention of cardiovascular disease in women

30 de ENE - 2024 Reproductive milestones across the lifespan and cardiovascular disease risk in women

30 de ENE - 2024 What is in a name? A decade after changing from VVA to GSM have we come any closer to ending the ‘silent suffering’ of postmenopausal women with genitourinary symptoms?

30 de ENE - 2024 Subjective cognitive changes following premenopausal risk-reducing bilateral salpingo- oophorectomy